Several faculty members won research grants from the Blavatnik Fund for Innovation at Yale at the fourth annual Yale Innovation Summit on May 10. The summit, presented by the Office of Cooperative Research (OCR) and Yale Entrepreneurial Institute, provides a window into an expanding entrepreneurial ecosystem at Yale, particularly around biotech and tech discoveries.
Farren Isaacs was part of the team that won Third Place in the biotech pitch contest. The team included: Sidera Medicine, targeting stem cell-like, invasive subpopulations of glioblastoma and melanoma with a new generation of highly selective small-molecule kinase drugs. The team included Jesse Rinehart, Ph.D., associate professor of cellular and molecular physiology; and Farren Isaacs, Ph.D., assistant professor of molecular, cellular, and developmental Biology.
For the complete story please visit medicine.yale.edu/news.